Serina Therapeutics, Inc. Share Price
AMEX: SER | Micro CapSerina Therapeutics, Inc. Stock Performance
Open $2.36 | Prev. Close $2.36 | Circuit Range N/A |
Day Range $2.34 - $2.37 | Year Range $1.24 - $7.79 | Volume 495 |
Average Traded $2.35 |
Serina Therapeutics, Inc. Share Price Today
As of 9 August 2026, Serina Therapeutics, Inc.'s share price is $2.39. The stock opened at $2.36, compared to its previous close of $2.36. During today's trading session, Serina Therapeutics, Inc.'s share price traded between $2.34 and $2.37, with an average price of $2.35. Over the past 52 weeks, the stock has recorded a high of $7.79 and a low of $1.24. In terms of performance, Serina Therapeutics, Inc.'s share price has risen by 33.52% over the last six months and is down 54.26% on a year-on-year basis.
Serina Therapeutics, Inc. Share Price Chart
Serina Therapeutics, Inc. Stock Fundamentals & Key Indicators
Market Cap $2578.81 | PE Ratio (TTM) -0.17 | Dividend Yield N/A |
EPS (TTM) $-13.72 | Revenue (TTM) -$40000.00 | Return On Equity (TTM) -207.93% |
Profit Margin 27852.50% | Debt to Equity 1.23 | Quarterly Earnings Growth YoY -425.18% |
Serina Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Serina Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Serina Therapeutics, Inc.
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Serina Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $2.04 | $2.37 | +13.40% |
Jul 2026 | $1.92 | $2.09 | +7.73% |
Jun 2026 | $1.82 | $1.94 | +4.30% |
May 2026 | $1.82 | $1.86 | +2.20% |
Apr 2026 | $2.00 | $1.82 | -6.19% |
Mar 2026 | $1.70 | $1.94 | +8.38% |
Feb 2026 | $2.98 | $1.79 | -41.69% |
Jan 2026 | $2.06 | $3.07 | +65.05% |
Dec 2025 | $3.70 | $1.86 | -56.03% |
Nov 2025 | $4.65 | $4.23 | -12.51% |
Oct 2025 | $5.29 | $4.83 | -9.29% |
Sep 2025 | $5.26 | $5.33 | +2.01% |